Latuda
Developed for schizophrenia, intended to target dopamine and serotonin receptors to alleviate auditory hallucinations and support improved cognitive function in patients.
- Category
- Mental Health
- Active ingredient
- Lurasidone
- Supply
- Rx
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 40 · 80mg
Latuda details
- Condition
- Schizophrenia
- Therapeutic class
- Atypical Antipsychotic
- Pharmacological class
- Second-Generation Antipsychotic
- Contraindications
- hypersensitivity to lurasidone
- Precautions and warnings
- patient monitoring required for glucose levels
- Minor side effects
- nausea; somnolence
- Moderate side effects
- akathisia; parkinsonism; dystonia
- Dosage forms
- Film-coated tablet
- Administration route
- Oral use
- Supply category
- Prescription only (specially controlled medicine)
- Manufacturer
- Angelini Pharma
- Onset Time
- 1–2 weeks
- Duration
- 24 hours
- Storage instructions
- Store below 30°C in the original carton to protect from light.
- Drug interactions
- grapefruit; strong CYP3A4 inhibitors
- Age restrictions
- Not recommended for children and adolescents under 18 years.
Serious side effects
neuroleptic malignant syndrome, requires immediate medical attention; tardive dyskinesia, requires immediate medical attention
Patient summary
Developed for schizophrenia, intended to target dopamine and serotonin receptors to alleviate auditory hallucinations and support improved cognitive function in patients.
Mechanism of action
Lurasidone acts as an antagonist at both dopamine D2 and serotonin 5-HT2A receptors. By blocking these receptors, it helps balance chemical signaling in the brain, which assists in managing the symptoms of schizophrenia and stabilizing mood in individuals with bipolar disorder.
Pregnancy and breastfeeding
Pregnancy: Use is not recommended unless clinically necessary. Breastfeeding: Breastfeeding should be discontinued during treatment.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Latuda
Latuda is a brand name for lurasidone, an antipsychotic medication used to manage symptoms of schizophrenia. It is supplied as a tablet in 40mg and 80mg strengths. Manufactured by Angelini Pharma, this treatment addresses chemical imbalances in the brain to help maintain mental stability.
Latuda availability in Asia
Latuda is registered across 14 markets, including Taiwan, South Korea and Japan, with availability also in the UAE, Singapore and Hong Kong. Patients often seek access to stable supplies of established treatments like lurasidone when living or working as expats in these regions. Because medication requirements vary, this treatment should be monitored by a doctor to ensure appropriate care.